ASCO, page-5

Looking good


Prof Guy van Hazel, co-principal investigator of SIRFLOX and Clinical Professor of Medicine at the University of Western Australia:“SIRFLOX gives us the data to validate the first-line use of selective internal radiation therapy, or SIRT, with SIR-Spheres Y-90 resin microspheres in mCRC.

"Until now, we have not had a randomized clinical study large enough to provide Level One evidence supporting first-line use of this treatment.

add the above to Prof Volker Heinemann as mentioned earlier

I reckon we could hit mid $30s